Senographe_Pristina

Senographe Pristina™

Choose the mammography system 83% of
patients say was a better experience.

Thank you for your interest in Senographe Pristina™! Please give us your details and we will have our representatives reach out to you.

Reshape the mammography experience with comfort, confidence and clarity

Reshape the Mammography experience
with a sensitive design.

Comfort for patients

Every woman is unique. Design can make a difference to better deal with challenging patients. The new, inviting gantry with elegant lighting and gentle, rounded shapes promotes a sense of calm.

Confidence for technologists

Poor positioning has been found to be the cause of most clinical imagedeficiencies and most failures of accreditation1. Technologist comfort is intimately linked to the patient’s one. The ergonomic design of Pristina eases patient positioning and improves the overall mammography experience for both patients and technologists.

Clarity for Radiologists

Superior diagnostic accuracy2 at the lowest patient dose of all FDAapproved digital breast tomosynthesis (DBT) systems3.

Senographe Pristina sets the bar high for diagnostic confidence and performance, leveraging the Senographe family’s widely recognized image quality. The Senographe Pristina platform is upgradeable to advanced applications.

Had a more positive experience on Senographe Pristina compared to previous exams4

Of technologists report thatSenographe Pristinawas easy to use

Senographe Pristina™ 3D
Superior Diagnostic Accuracy

Digital
Mammography

Digital Breast
Tomosynthesis

Tomosynthesis and synthetic 2D images, a 3D dose-equivalent solution for screening mammography

Digital Breast Tomosynthesis (DBT) is a three-dimensional (3D) imaging technology that uses a low-dose limited angle X-ray sweep around compressed breasts to produce 3D images that reduce image quality issues associated with overlapping structures (superimposition), a limitation in standard two-dimensional (2D) mammography.

Breast cancer detection randomized trial on tomosynthesis -Reggio Emilia5: 2D + 3D mammography for finding breast cancer compared to 2D mammography alone

FFDM (left) and V-Preview 4.1 (right) for same patient

9 projections over 25° has been chosen to preserve the visibility of small objects and tissue depth separation.

Senographe Pristina design

An attractive and well-designed gantry.

Senographe Pristina mammography system is more inviting and more comfortable resulting in a better overall breast exam experience. It was designed to ease anxiety when the patient enters the exam room.

The new, inviting gantry promotes a sense of calm, with elegantlighting and gentle, rounded shapes.
A soft-curved surface invites patients into a space of comfort andsupport.
The nice shapes and colors provide a sensation of calm, reduce patient anxiety and make the examination a more positive experience.6
Bucky thinness allows the better positionning of the patient on the breast support.

ProFound™ AI by ICAD

Address the challenge of reading an increasing amount of cases.

Reading tomosynthesis cases means being able to accurately interpret extensive amounts of data.

Deep learning based ProFound™ AI is changing the paradigm by offering radiologists the possibility to address the challenges of reading an increasing amount of tomosynthesis cases with a high-performing, concurrent-read, workflow solution that rapidly and accurately analyzes each tomosynthesis plane, detecting both malignant soft tissue densities and calcifications with exceptional accuracy.

Integrated with Seno Iris.
ProFound AI displays case scores in the worklist.
The Case Score represents how confident the algorithm is that a case is malignant, taking into account all detections in the case.

Reduce
reading time

Increase
sensitivity

Increase
specificity

Reduce
recalls

Seamless integration with Seno™ Iris: ProFound AI displays a case scores in the worklist

ProFound AI detect both malignant soft tissue densities and calcifications with exceptional accuracy findings are marked on the 2D synthetized view, on the slabs and on the planes of interest

U.S.Food and Drug Administration http://www.fda.gov/Radiation. EmittingProducts/MammographyQualityStandards ActandProgram/FacilityScorecard/ucm495378.htm
Superior diagnostic accuracy demonstrated in a reader study comparing the ROC AUC of GE screening protocol (V-Preview + 3D CC/MLO with 3D in STD mode) to that of 2D FFDM alone. V-Preview is the 2D synthesized image generated by GE Seno Iris mammography software from GE DBT images. FDA PMA P130020 http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/ cfpma/pma.cfm?id=P130020.
Comparison of patient dose delivered by FDA approved DBT devices as of February 2018 for a breast of average density, based on data presented in [1-2] and data on file. Device comparison includes GE SenoClaire, GE Senographe Pristina 3D in STD mode, Hologic Selenia Dimensions, Siemens Mammomat Inspiration, Fuji Aspire Cristalle [1. Bouwman, R. W. and al., et. 2015, Physics in Medicine & Biology, pp. 7893-7907; 2. NHSBSP Equipment Reports 1306, 1404, 1307, and on Fujifilm AMULET Innovality.]
IPSOS Patient Satisfaction Study sponsored by GE Healthcare, conducted with 315 patients across 2 sites in Europe, February 2017
Digital Mammography versus Digital Mammography plus tomosynthesis for Breast Cancer Screening: The Reggio Emilia Tomosynthesis Randomized Trial.https://doi.org/10.1148/radiol.20181721
1 IPSOS Patient Satisfaction Study sponsored by GE Healthcare, conducted with 315 patients across 2 sites in Europe, February 2017